FindTrial
Sign In

None. Observational study.

OTHER2 trials

Sponsors

Pfizer, Värmland County Council, Sweden

Conditions

Autism DisorderSchizophrenia and Other Psychotic DisordersTransthyretin AmyloidosisTransthyretin Gene Mutations

Unknown Phase

Transthyretin Amyloidosis Outcome Survey (THAOS)
CompletedNCT00628745
PfizerTransthyretin Amyloidosis, Transthyretin Gene Mutations
Start: 2008-01-04End: 2023-06-19Updated: 2024-11-22
Follow-up of Adolescents With Autism and Psychotic Symptoms - Psychiatric Co-morbidity and Functional Impairment.
RecruitingNCT07427810
Värmland County Council, SwedenAutism Disorder, Schizophrenia and Other Psychotic Disorders
Start: 2026-07-13End: 2027-12-01Target: 53Updated: 2026-09-02

Related Papers

Sex Differences in a Contemporary, Real-World Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.
2026-09-04
Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis
Cardiology and Therapy2026-08-27
A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summary
Future Cardiology2025-11-25
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS
Cardiology and Therapy2025-07-091 citations
Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis
JACC Advances2024-07-129 citations
Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS).
2024-06-2123 citations
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
PLoS ONE2024-01-198 citations
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
Cardiology and Therapy2023-12-2018 citations
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
2023-11-1034 citations
A natural history analysis of asymptomatic <i>TTR</i> gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Amyloid2022-06-2222 citations
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.
2022-06-1854 citations
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
2022-05-1821 citations
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Amyloid2022-04-2227 citations
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
2022-02-01111 citations
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
2021-10-1947 citations
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
Neurology and Therapy2021-07-3022 citations
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS
Cardiology and Therapy2021-06-1915 citations
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
2021-05-2224 citations
Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)
Autonomic Neuroscience2019-10-2335 citations
A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy
Amyloid2019-07-2729 citations

7 more papers not shown